06/28/2024 | Press release | Distributed by Public on 06/28/2024 06:40
Item 5.07 Submission of Matters to a Vote of Security Holders.
Candel Therapeutics, Inc., a Delaware corporation (the "Company"), held its Annual Meeting of Stockholders (the "Annual Meeting") on June 26, 2024. As of May 15, 2024, the record date for the Annual Meeting, there were 29,756,005 outstanding shares of the Company's voting common stock. The Company's stockholders voted on the following matters, which are described in detail in the Company's Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission on May 30, 2024: (i) to elect three directors, Nicoletta Loggia, Ph.D., R.Ph., Christopher Martell, and Diem Nguyen, Ph.D., M.B.A., as Class III directors of the Company to serve for a three-year term expiring at the Company's 2027 annual meeting of stockholders and until their successor has been duly elected and qualified, subject to their earlier death, resignation or removal ("Proposal 1") and (ii) to ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 ("Proposal 2").
The Company's stockholders elected each of the Class III director nominees, Nicoletta Loggia, Ph.D., R.Ph., Christopher Martell, and Diem Nguyen, Ph.D., M.B.A., recommended for election at the Annual Meeting in Proposal 1. The votes cast at the Annual Meeting were as follows:
For |
Against |
Abstain |
Broker Non-Votes |
|||||||||||
Nicoletta Loggia, Ph.D., R.Ph. |
7,181,872 |
150,389 |
- |
7,427,258 |
||||||||||
Christopher Martell |
6,994,015 |
338,246 |
- |
7,427,258 |
||||||||||
Diem Nguyen, Ph.D., M.B.A. |
7,020,058 |
312,203 |
- |
7,427,258 |
The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, recommended for ratification in Proposal 2 at the Annual Meeting. The votes cast at the Annual Meeting were as follows:
For |
Against |
Abstain |
||||||||
14,617,652 |
98,945 |
42,922 |
No other matters were submitted to or voted on by the Company's stockholders at the Annual Meeting.